Medicomp has been developing, manufacturing and serving reliable & sophisticated ambulatory heart-monitoring systems since 1981. Medicomp takes great pride in advancing new technology, improving existing technologies, and adding new applications for ambulatory cardiac monitoring
Competitive Advantage in Holter Monitoring
Medicomp is structured with a physician as the CEO of the company. With the company being lead by a Medical Doctor, Medicomp sees a clinical perspective in cardiology being a distinct advantage among the competition. In addition to their clinical strength, Medicomp also sees their competitive advantage in their device technology. Medicomp is unique in the industry being one of the only companies that actually develops and produces all of its own products while others choose to outsource overseas. Medicomp claims to be widely regarded as the most advanced technology in the industry.
Holter Device Technology
Medicomp has developed their own patented ‘Diogenes’ algorithm for detecting asymptomatic arrhythmias. According to Medicomp, the ‘Diogenes’ is only algorithm available that provides beat-to-beat analysis of the P wave as well as Rate, Rhythm, and QRS morphology. This algorithm is embedded not only in their Holter Monitoring technology, but also with their Cardiac Event Monitors and Mobile Cardiac Telemetry.
Medicomp offers a full suite of ambulatory monitoring solutions with seamless integration into electronic medical records system (EMR). For more information, click Medicomp Decipher Holter Monitor
Medicomp is a Independent Diagnostic Testing Facility (IDTF) accredited with Centers for Medicare and Medicaid (CMS).
Legal & Safety Notice
Medicomp has a sound reputation for manufacturing and regulatory processes. To date, there is no public notice of any legal disputes with their technology. Medicomp may be the only MCT company to remain out of litigation with the big service companies such as LifeWatch and CardioNet.